274 related articles for article (PubMed ID: 24434353)
1. Molecular mechanisms of congenital heart block.
Ambrosi A; Sonesson SE; Wahren-Herlenius M
Exp Cell Res; 2014 Jul; 325(1):2-9. PubMed ID: 24434353
[TBL] [Abstract][Full Text] [Related]
2. Neonatal lupus: bedside to bench and back.
Buyon JP
Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
[TBL] [Abstract][Full Text] [Related]
3. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
Ayed K; Gorgi Y; Sfar I; Khrouf M
Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
[TBL] [Abstract][Full Text] [Related]
4. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
[TBL] [Abstract][Full Text] [Related]
5. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus.
Buyon JP; Ben-Chetrit E; Karp S; Roubey RA; Pompeo L; Reeves WH; Tan EM; Winchester R
J Clin Invest; 1989 Aug; 84(2):627-34. PubMed ID: 2760204
[TBL] [Abstract][Full Text] [Related]
6. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies.
Ambrosi A; Wahren-Herlenius M
Arthritis Res Ther; 2012 Apr; 14(2):208. PubMed ID: 22546326
[TBL] [Abstract][Full Text] [Related]
7. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model.
Miranda-Carús ME; Boutjdir M; Tseng CE; DiDonato F; Chan EK; Buyon JP
J Immunol; 1998 Dec; 161(11):5886-92. PubMed ID: 9834068
[TBL] [Abstract][Full Text] [Related]
8. Ro/SSA autoantibody-positive pregnancy: reactions to serial fetal Doppler echocardiographic surveillance.
Tingström J; Hjelmstedt A; Welin Henriksson E; Sonesson SE; Wahren-Herlenius M
Lupus; 2015 Dec; 24(14):1540-5. PubMed ID: 26113358
[TBL] [Abstract][Full Text] [Related]
9. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
[TBL] [Abstract][Full Text] [Related]
10. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.
Clancy RM; Neufing PJ; Zheng P; O'Mahony M; Nimmerjahn F; Gordon TP; Buyon JP
J Clin Invest; 2006 Sep; 116(9):2413-22. PubMed ID: 16906225
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune-mediated congenital heart block.
Wainwright B; Bhan R; Trad C; Cohen R; Saxena A; Buyon J; Izmirly P
Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():41-51. PubMed ID: 31685414
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block.
Boutjdir M; Chen L; Zhang ZH; Tseng CE; DiDonato F; Rashbaum W; Morris A; el-Sherif N; Buyon JP
Circ Res; 1997 Mar; 80(3):354-62. PubMed ID: 9048655
[TBL] [Abstract][Full Text] [Related]
13. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes.
Miranda ME; Tseng CE; Rashbaum W; Ochs RL; Casiano CA; Di Donato F; Chan EK; Buyon JP
J Immunol; 1998 Nov; 161(9):5061-9. PubMed ID: 9794444
[TBL] [Abstract][Full Text] [Related]
14. Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel.
Karnabi E; Qu Y; Wadgaonkar R; Mancarella S; Yue Y; Chahine M; Clancy RM; Buyon JP; Boutjdir M
J Autoimmun; 2010 Mar; 34(2):80-6. PubMed ID: 19640679
[TBL] [Abstract][Full Text] [Related]
15. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
16. Immunological aspects of congenital atrioventricular block.
Smeenk RJ
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2093-7. PubMed ID: 9272516
[TBL] [Abstract][Full Text] [Related]
17. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies.
Askanase AD; Friedman DM; Copel J; Dische MR; Dubin A; Starc TJ; Katholi MC; Buyon JP
Lupus; 2002; 11(3):145-51. PubMed ID: 11999879
[TBL] [Abstract][Full Text] [Related]
18. [Apropos of the article by Y. Finkelstein et al.: "Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block"].
Herreman G
Ann Med Interne (Paris); 1997; 148(8):582. PubMed ID: 9565543
[No Abstract] [Full Text] [Related]
19. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.
Nield LE; Silverman ED; Taylor GP; Smallhorn JF; Mullen JB; Silverman NH; Finley JP; Law YM; Human DG; Seaward PG; Hamilton RM; Hornberger LK
Circulation; 2002 Feb; 105(7):843-8. PubMed ID: 11854125
[TBL] [Abstract][Full Text] [Related]
20. Interferons and innate immune activation in autoimmune congenital heart block.
Ambrosi A; Thorlacius GE; Sonesson SE; Wahren-Herlenius M
Scand J Immunol; 2021 Jan; 93(1):e12995. PubMed ID: 33188653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
